Guided Therapeutics (OTCMKTS:GTHP) Posts Quarterly Earnings Results

Guided Therapeutics (OTCMKTS:GTHP) issued its quarterly earnings results on Monday. The company reported ($0.02) earnings per share (EPS) for the quarter, Zacks reports.

Guided Therapeutics Stock Performance

OTCMKTS GTHP remained flat at $0.10 on Monday. The company’s stock had a trading volume of 5 shares, compared to its average volume of 12,867. The stock has a market cap of $7.76 million, a price-to-earnings ratio of -3.32 and a beta of 0.50. The firm has a fifty day moving average price of $0.11 and a 200-day moving average price of $0.15. Guided Therapeutics has a 52 week low of $0.06 and a 52 week high of $0.23.

Guided Therapeutics Company Profile

Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.